EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy

Ambika Ramesh, Akshith Doddi, Aisha Abbasi, Mohammad A Al-Mamun, Ankit Sakhuja, Khaled Shawwa iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0315643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Ambika Ramesh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, West Virginia University, Morgantown, West Virginia, United States of America. Hauptthemen laut MEDLINE: Acute Kidney Injury, Vasoconstrictor Agents, Hospital Mortality, Continuous Renal Replacement Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate whether the use of a specific vasopressor was associated with increased mortality or adverse outcomes in patients with acute kidney injury (AKI) receiving continuous kidney replacement therapy (CKRT).

Methods

Patients with AKI who underwent CKRT between 1/1/2012-1/1/2021 at a tertiary academic hospital were included. Cox proportional hazard model was used to assess the relationship between time-dependent vasopressor dose and in-hospital mortality.

Results

There were 641 patients with AKI that required CKRT. In-hospital mortality occurred in 318 (49.6%) patients. Those who died were older (63 vs 57 years), had higher SOFA score (10.6 vs 9) and lactate (6 vs 3.3 mmol/L). In multivariable model, increasing doses of norepinephrine [HR 4.4 (95% CI: 2.3–7, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryVasoconstrictor AgentsHospital MortalityContinuous Renal Replacement TherapyHumansMiddle AgedMaleFemaleAgedNorepinephrineProportional Hazards ModelsRetrospective StudiesVasopressinsRenal Replacement Therapy

Substanzen

Vasoconstrictor AgentsNorepinephrineVasopressins

Autor:innen und Institutionen

  • Department of Medicine, West Virginia University, Morgantown, West Virginia, United States of America.
  • Department of Pharmaceutical Systems and Policy, West Virginia University, Morgantown, West Virginia, United States of America.
  • Division of Data-Driven and Digital Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Division of Nephrology, Department of Medicine, West Virginia University, Morgantown, West Virginia, United States of America.

ORCID-Profile: Khaled Shawwa

Förderung

  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Ramesh, A., Doddi, A., Abbasi, A., Al-Mamun, M. A., Sakhuja, A., & Shawwa, K. (2024). Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy. PLOS ONE. https://doi.org/10.1371/journal.pone.0315643

Vancouver

Ramesh A, Doddi A, Abbasi A, Al-Mamun MA, Sakhuja A, Shawwa K. Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy. PLOS ONE. 2024. doi:10.1371/journal.pone.0315643

BibTeX
@article{Ramesh2024,
  author = {Ramesh, Ambika and Doddi, Akshith and Abbasi, Aisha and Al-Mamun, Mohammad A and Sakhuja, Ankit and Shawwa, Khaled},
  title = {Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0315643}
}
Kostenlos starten →